Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The researchers collect treatment-naive H.pylori-positive patients from the outpatient
clinic. The subjects were randomized to receive a 10-day or 14-day course of quadruple
eradication therapy. 6-8 weeks after treatment, the subjects will re-take the 13C-urea breath
test. Calculate the eradication rates, adverse reaction rates, patient compliance and
cost-effectiveness index of each group.
Phase:
Phase 4
Details
Lead Sponsor:
Shandong University
Collaborators:
Heze Municipal 3rd people's hospital Maternity and Child Care Health Center of Dezhou PKUcare luzhong hospital The First Affiliated Hospital with Nanjing Medical University